Search results for "Prostate cancer"
Little difference found among prostate cancer treatments regarding clinical results, patient-reported outcomes
More men in the active-monitoring group developed metastases than in the surgery or radiotherapy groups, and there were higher rates of disease progression in the active-monitoring group than in the surgery or radiotherapy groups.
https://immattersacp.org/weekly/archives/2016/09/20/2.htm
20 Sep 2016
Decision aids increased knowledge about prostate cancer but didn't affect screening rates
Decision aids improved participants' informed decision making about prostate cancer screening but did not change the actual screening rates, a study found.
https://immattersacp.org/weekly/archives/2013/08/06/2.htm
6 Aug 2013
New guidance urges caution on testosterone
Internists considering testosterone therapy are ideally positioned to consider a broader differential diagnosis that will actually help the patient.
https://immattersacp.org/archives/2020/05/new-guidance-urges-caution-on-testosterone.htm
1 May 2020
Age, comorbidity should inform decisions on how to treat low- or intermediate- risk prostate cancer
Older men with prostate cancer and multiple major comorbid conditions are at high risk for other-cause mortality within 10 years of diagnosis and should consider this when deciding between conservative management and aggressive treatment for low- or intermediate-risk disease, a study concluded.
https://immattersacp.org/weekly/archives/2013/05/21/2.htm
21 May 2013
Comorbid illnesses still more likely to kill prostate cancer survivors
Veterans Affairs solicits applications for centers of excellence
https://immattersacp.org/weekly/archives/2010/08/31/6.htm
31 Aug 2010
Squeezing in the cancer screening talk
By making the most of team members and technology, internists can free up valuable physician-patient interaction time to most effectively apply cancer screening guidelines.
https://immattersacp.org/archives/2019/10/squeezing-in-the-cancer-screening-talk.htm
1 Oct 2019
Warnings added to prostate cancer drugs
Talk about health care reform with CMS Administrator Don BerwickPQRI incentive payments now being sentAre you enrolled in PECOS?
https://immattersacp.org/weekly/archives/2010/10/26/7.htm
26 Oct 2010
Decision aids integral to shared decision making
When used properly and in the correct situation, decision aids save time and costs by better meeting patient needs and increasing adherence.
https://immattersacp.org/archives/2019/05/decision-aids-integral-to-shared-decision-making.htm
1 May 2019
Treatment for prostate symptoms doesn't appear to increase risk for advanced prostate cancer
Treating prostate symptoms with 5α-reductase inhibitors (5-ARIs) does not appear to increase risk for advanced prostate cancer, a new study indicates.
https://immattersacp.org/weekly/archives/2013/06/25/1.htm
25 Jun 2013
Docetaxel may prolong prostate cancer survival in patients with metastasis
Docetaxel added to the start of hormone therapy for metastatic prostate cancer may prolong survival compared to patients who received hormone therapy alone, according to early results from a trial.
https://immattersacp.org/weekly/archives/2013/12/17/4.htm
17 Dec 2013